Is plasma renin activity a biomarker for the prediction of renal and cardiovascular outcomes in treated hypertensive patients? Observations from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)

Metabolic syndrome, impaired fasting glucose and obesity, as predictors of incident diabetes in 14 120 hypertensive patients of ASCOT-BPLA: comparison of their relative predictability using a novel approach

(2011) A. K. Gupta et al.   DIABETIC MEDICINE

Plasma renin activity predicts cardiovascular mortality in the Heart Outcomes Prevention Evaluation (HOPE) study

(2011) Subodh Verma et al.   EUROPEAN HEART JOURNAL

The Anglo-Scandinavian Cardiac Outcomes Trial: 11-year mortality follow-up of the lipid-lowering arm in the UK

(2011) Peter S. Sever et al.   EUROPEAN HEART JOURNAL

Evaluation of C-reactive protein prior to and on-treatment as a predictor of benefit from atorvastatin: observations from the Anglo-Scandinavian Cardiac Outcomes Trial

(2011) P. S. Sever et al.   EUROPEAN HEART JOURNAL

Association of plasma renin activity and aldosterone–renin ratio with prevalence of chronic kidney disease

(2011) John J. Sim et al.   JOURNAL OF HYPERTENSION

Relation of Elevated Plasma Renin Activity at Baseline to Cardiac Events in Patients With Angiographically Proven Coronary Artery Disease

(2010) Joseph B. Muhlestein et al.   AMERICAN JOURNAL OF CARDIOLOGY

Elevated Plasma Renin Activity Predicts Adverse Outcome in Chronic Heart Failure, Independently of Pharmacologic Therapy: Data From the Valsartan Heart Failure Trial (Val-HeFT)

(2010) Serge Masson et al.   JOURNAL OF CARDIAC FAILURE

Review: Measurement of plasma renin: a critical review of methodology

(2010) Michel Azizi et al.   JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM

Review: Plasma renin and the incidence of cardiovascular disease

(2010) Tom Meade   JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM